Photo of Chanland (Chan) Roonprapunt

Chanland (Chan) Roonprapunt

  • ASSISTANT PROFESSOR Neurosurgery
Print ProfilePrint Profile

Biography

    Chan Roonprapunt, MD, PhD, is a board-certified neurosurgeon, based at Mount Sinai Roosevelt Hospital with office hours at Mount Sinai Beth Israel Phillips Ambulatory Care Center. He has a broad experience in the treatment of surgical disorders of the nervous system. He has a special interest in Chiari Malformations, syringomyelia, and spinal conditions. Dr. Roonprapunt completed his neurosurgical training at Montefiore Medical Center and Roosevelt Hospital of New York, NY. He continued his training with an orthopedic spine fellowship at the Beth Israel Spine Institute of New York, where he gained a significant experience in spinal instrumentation in the management of spinal degeneration and deformity. With a unique background in neurosurgery and orthopedic spine, he is prepared to treat all spine conditions, by utilizing minimally invasive techniques of decompression and stabilization. He also has experience in artificial disc replacement in the cervical and lumbar spine. He has published multiple book chapters and articles in the neurosurgical literature regarding management of Chiari Malformations and intramedullary spinal tumors. He has lectured nationally on these topics. Dr. Roonprapunt graduated from the medical scientist training program at New York University School of Medicine, where he received MD and PhD degrees. His PhD thesis involved the study of acute spinal cord injury. He earned his B.A. degree in Biology at Cornell University. He has been recognized within the “Guide to America’s Top Surgeons 2007” by the Consumer’s Research Council of America and Strathmore’s “Who’s Who 2007-2008.” He has had the “Patient’s Choice Award” and “Compassionate Doctor Award” from American Registry from 2010-2013.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Roonprapunt did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

1000 10th Avenue
Suite 5G-80
New York, NY 10019

Tel: 212-636-4671
Fax: 212-523-6115